<\/p>\n
NEW FILINGS<\/strong><\/p>\n Company: NYXOAH SA Company: Xiaoju Kuaizhi Inc. Company: Ocean Biomedical Inc. Company: Aerovate Therapeutics Inc. Company: Acumen Pharmaceuticals Inc. Company: Dingdong (Cayman) Limited Company: Missfresh Limited Company: Atour Lifestyle Holdings Limited Company: Torrid Holdings, Inc. Company: Clear Secure, Inc. Company: LegalZoom.com Inc. Company: CVRx, Inc. Company: Graphite Bio, Inc. Company: Intapp, Inc. Company: GH Research PLC Company: Alpha Teknova, Inc. Company: Elevation Oncology, Inc. Company: Monte Rosa Therapeutics, Inc. UPDATED TERMS<\/strong><\/p>\n Company: Lyell Immunopharma, Inc. Company: Molecular Partners Inc. Company: Unicycive Therapeutics Inc. Company: WalkMe Ltd. Company: AMTD Digital, Inc. Company: Angel Oak Mortgage, Inc. Company: Convey Holding Parent, Inc.
\nSymbol: NYXH (Nasdaq)
\nDescription: They are a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea, or OSA.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriters: Piper Sandler, Stifel, Cantor
\nCo Manager: Degroof Petercam
\nLink to Prospectus: Filed: 6-10-21<\/p>\n
\nSymbol: DIDI (NYSE)
\nDescription: They are the world’s largest mobility technology platform. They are the go-to brand in China for shared mobility, providing consumers with a comprehensive range of safe, affordable and convenient mobility services, including ride hailing, taxi hailing, chauffeur, hitch and other forms of shared mobility.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriters: Goldman Sachs, Morgan Stanley, JP Morgan
\nCo Manager: China Renaissance
\nLink to Prospectus: Filed: 6-10-21
\nListed Cash Raise: $100m<\/p>\n
\nSymbol: OCEA (Nasdaq)
\nDescription: They are a biopharmaceutical company that seeks to bridge the \u201cbench-to-bedside\u201d gap between medical research discoveries and patient solutions.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriters: Berenberg, Oppenheimer & Co.
\nCo Manger: LifeSci Capital, Ladenburg Thalmann, Brookline Capital Markets, Roth Capital
\nLink to Prospectus: Filed: 6-9-21
\nListed Cash Raise: $100m<\/p>\n
\nSymbol: AVTE (Nasdaq)
\nDescription: They are a clinical stage biopharmaceutical company focused on developing drugs that meaningfully improve the lives of patients with rare cardiopulmonary disease.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriters: Jefferies, Cowen, Evercore
\nCo Manger: Wedbush PacGrow
\nLink to Prospectus: Filed: 6-9-21
\nListed Cash Raise: $100m<\/p>\n
\nSymbol: ABOS (Nasdaq)
\nDescription: They are a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what we believe to be a key underlying cause of Alzheimer\u2019s disease, or AD.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriters: BofA Securities, Credit Suisse, Stifel
\nCo Manger: UBS Investment Bank
\nLink to Prospectus: Filed: 6-9-21
\nListed Cash Raise: $100m<\/p>\n
\nSymbol: DDL (NYSE)
\nDescription: They are a leading and the fastest growing on-demand e-commerce company in China, according to China Insights Consultancy, or CIC.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriters: Morgan Stanley, BofA Securities, Credit Suisse
\nLink to Prospectus: Filed: 6-8-21
\nListed Cash Raise: $100m<\/p>\n
\nSymbol: MF
\nDescription: Missfresh is rebuilding neighborhood retail from the ground up in China with our innovative technology and business model.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriters: JP Morgan, Citigroup, CICC, China Renaissance
\nCo-Manager(s): CMBI, ICBC International, Needham & Co., FUTU, Tiger Brokers
\nLink to Prospectus: Filed: 6-8-21
\nListed Cash Raise: $100m<\/p>\n
\nSymbol: ATAT
\nDescription: They are the largest upper midscale hotel chain in China in terms of room number as of the end of 2020, according to Frost & Sullivan.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriters: BofA Securities, Citigroup
\nCo-Manager(s): CICC, CMBI
\nLink to Prospectus: Filed: 6-8-21
\nListed Cash Raise: $100m<\/p>\n
\nSymbol: CURV (NYSE)
\nDescription: Torrid is the largest direct-to-consumer brand of women\u2019s plus-size apparel and intimates in North America by net sales.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriters: Morgan Stanley, BofA Securities, Goldman Sachs, Jefferies
\nCo-Manager(s): Baird, Cowen, William Blair, Telsey Advisory Group
\nLink to Prospectus: Filed: 6-7-21
\nListed Cash Raise: $100m
\nCompany Originally Filed in July 2017<\/p>\n
\nSymbol: YOU (NYSE)
\nDescription: They have built an extensive physical footprint with a nationwide network of airports, stadiums and businesses to offer members frictionless, trusted experiences as they move and transact throughout the day in both physical and digital environments.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriters: Goldman Sachs, JP Morgan, Allen & Co., Wells Fargo
\nCo-Manager(s): LionTree, Stifel, Telsey Advisory Group, Centerview Partners, Loop Capital, Roberts & Ryan
\nLink to Prospectus: Filed: 6-7-21
\nListed Cash Raise: $100m<\/p>\n
\nSymbol: LZ
\nDescription: LegalZoom is a leading online platform for legal and compliance solutions in the United States. In 2020, 10% of new limited liability companies, or LLCs, and 5% of new corporations in the United States were formed via LegalZoom.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriters: JP Morgan, Morgan Stanley, Barclays, BofA Securities, Citigroup, Credit Suisse, Jefferies
\nCo-Manager(s): JMP Securities, Raymond James, William Blair
\nLink to Prospectus: Filed: 6-4-21
\nListed Cash Raise: $100m<\/p>\n
\nSymbol: CVRX
\nDescription: They are a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative and minimally invasive neuromodulation solutions for patients with cardiovascular diseases.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriters: JP Morgan, Piper Sandler, William Blair
\nCo-Manager(s): Canaccord Genuity
\nLink to Prospectus: Filed: 6-4-21
\nListed Cash Raise: $75m<\/p>\n
\nSymbol: GRPH
\nDescription: They are a clinical-stage, next-generation gene editing company harnessing high efficiency targeted gene integration to develop a new class of therapies to potentially cure a wide range of serious and life-threatening diseases.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriters: Morgan Stanley, BofA Securities, Cowen, SVB Leerink
\nLink to Prospectus: Filed: 6-4-21
\nListed Cash Raise: $100m<\/p>\n
\nSymbol: INTA
\nDescription: Intapp is a leading provider of industry-specific, cloud-based software solutions for the professional and financial services industry globally.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriters: JP Morgan, BofA Securities, Credit Suisse
\nCo-Manager(s): Piper Sandler, Raymond James, Oppenheimer, Stifel, Truist Securities
\nLink to Prospectus: Filed: 6-4-21
\nListed Cash Raise: $100m<\/p>\n
\nSymbol: GHRS
\nDescription: They are a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriters: Cowen, Stifel
\nCo-Manager(s): Canaccord Genuity, JMP Securities
\nLink to Prospectus: Filed: 6-4-21
\nListed Cash Raise: $100m<\/p>\n
\nSymbol: TKNO
\nDescription: They are a leading provider of critical reagents that enable the discovery, research, development and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriters: Cowen, William Blair
\nCo-Manager(s): BTIG, Stephens
\nLink to Prospectus: Filed: 6-4-21
\nListed Cash Raise: $75m<\/p>\n
\nSymbol: ELEV
\nDescription: They are a precision oncology company focused on the development of targeted therapeutics for the treatment of cancer in genomically-defined patient populations.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriters: JP Morgan, Cowen, SVB Leerink
\nCo-Manager(s): Wedbush PacGrow
\nLink to Prospectus: Filed: 6-4-21
\nListed Cash Raise: $100m<\/p>\n
\nSymbol: GLUE
\nDescription: They are a biopharmaceutical company developing a portfolio of novel small molecule precision medicines that employ the body\u2019s natural mechanisms to selectively degrade therapeutically-relevant proteins.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriters: JP Morgan, Cowen, Piper Sandler, Guggenheim
\nLink to Prospectus: Filed: 6-4-21
\nListed Cash Raise: $100m<\/p>\n
\nSymbol: LYEL
\nDescription: They are a T cell reprogramming company dedicated to the mastery of T cells to cure patients with solid tumors.
\nShares: 25 million
\nPrice Range: $16.00-$18.00
\nMarket Cap: $3.9b-$4.4b
\nTrade Date: Thursday, 6\/17
\nUnderwriter(s): Goldman Sachs, BofA Securities, JP Morgan, Morgan Stanley
\nLink to Prospectus: Terms Added: 6-9-21<\/p>\n
\nSymbol: MOLN
\nDescription: They are a clinical stage biopharmaceutical company applying our pioneering DARPin\u00ae product candidates to treat serious diseases, with a current focus on infectious disease, oncology and ophthalmology.
\nShares: 3 million ADSs
\nPrice Range: $27.14-$27.14
\nMarket Cap: $873m-$873m
\nTrade Date: Wednesday, 6\/16
\nUnderwriter(s): JP Morgan, SVB Leerink, Cowen, RBC Capital
\nCo-Manager: Kempen & Co.
\nLink to Prospectus: Terms Added: 6-9-21
\nListed Cash Raise: $100m
\nNote: Their common shares are listed on the SIX Swiss Exchange Ltd, or the SIX Swiss Exchange, under the symbol \u201cMOLN\u201d.<\/p>\n
\nSymbol: UNCY
\nDescription: They are a biotechnology company dedicated to developing treatments for certain medical conditions.
\nShares: 2.6 million
\nPrice Range: $8.50-$10.50
\nMarket Cap: $100m-$124m
\nTrade Date: Friday, 6\/18
\nUnderwriter(s): Roth Capital
\nCo Managers: Kingswood Capital
\nLink to Prospectus: Terms Added: 6-7-21<\/p>\n
\nSymbol: WKME
\nDescription: They are the defining solution enabling organizations to better realize the value of their software investments.
\nShares: 9.25 million
\nPrice Range: $29.00-$32.00
\nMarket Cap: $2.4b-$2.65b
\nTrade Date: Wednesday 6\/16
\nUnderwriter(s): Morgan Stanley, Goldman Sachs, Citigroup
\nCo Managers: Wells Fargo, Barclays, BMO Capital, JMP Securities, KeyBanc Capital Markets, Needham & Company
\nLink to Prospectus: Terms Added: 6-7-21<\/p>\n
\nSymbol: HKD
\nDescription: They are one of the most comprehensive digital solutions platforms in Asia with businesses spanning multiple verticals, including digital financial services, SpiderNet ecosystem solutions, digital media, content, and marketing, and digital investments.
\nShares: 16 million ADSs
\nPrice Range: $6.80-$8.20
\nMarket Cap: $1.3b-$1.5b
\nTrade Date: Tuesday, 6\/15
\nUnderwriter(s): AMTD
\nCo Managers: Loop Capital, Maxim Group, Livermore Holdings
\nLink to Prospectus: Terms Added: 6-7-21<\/p>\n
\nSymbol: AOMR
\nDescription: Angel Oak Mortgage, Inc. is a real estate finance company focused on acquiring and investing in first lien non-QM loans and other mortgage-related assets in the U.S. mortgage market.
\nShares: 8.05 million
\nPrice Range: $20.00-$21.00
\nMarket Cap: $524m-$551m
\nTrade Date: Thursday, 6\/17
\nUnderwriter(s): Wells Fargo, BofA Securities, Morgan Stanley, UBS Investment Bank, B.Riley Securities
\nCo Managers: Nomura, Oppenheimer & Co.
\nLink to Prospectus: Terms Added: 6-8-21<\/p>\n
\nSymbol: CNVY (NYSE)
\nDescription: Convey Health is a leading healthcare platform that utilizes technology and processes to improve government-sponsored health plans, including Medicare Advantage (\u201cMA\u201d).
\nShares: 13.3 million
\nPrice Range: $14.00-$16.00
\nMarket Cap: $1.0b-$1.2b
\nTrade Date: Wednesday, 6\/16
\nUnderwriter(s): BofA Securities, Goldman Sachs, JP Morgan, Barclays
\nCo Managers: TPG Capital BD LLC, Truist Securities, Canaccord Genuity
\nLink to Prospectus: Terms Added: 6-7-21<\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"zakra_general_container_width":0,"zakra_general_content_width":0,"zakra_general_sidebar_width":0,"zakra_sticky_header":"customizer","zakra_header_main_area":true,"zakra_site_logo_width":0,"zakra_header_top_enabled":"customizer","zakra_header_top_style":"customizer","zakra_primary_menu_item_style":"customizer","zakra_page_header_text_color":"","zakra_page_header_layout":"customizer","zakra_page_title_bg":"","zakra_footer_widgets_bg_image":0,"zakra_page_title_bg_repeat":"customizer","zakra_page_title_bg_position":"customizer","zakra_page_title_bg_size":"customizer","zakra_page_title_bg_attachment":"customizer","zakra_breadcrumbs_enabled":"customizer","zakra_breadcrumbs_text_color":"","zakra_breadcrumbs_separator_color":"","zakra_breadcrumbs_link_color":"","zakra_breadcrumbs_link_hover_color":"","zakra_page_title_bg_image":0,"zakra_footer_widgets_enabled":"customizer","zakra_footer_column_layout_1_style":"customizer","zakra_footer_widgets_bg":"","zakra_footer_widgets_bg_repeat":"customizer","zakra_footer_widgets_bg_position":"customizer","zakra_footer_widgets_bg_size":"customizer","zakra_footer_widgets_bg_attachment":"customizer","zakra_footer_bar_enabled":"customizer","zakra_footer_bar_style":"customizer","footnotes":""},"categories":[1536],"tags":[],"class_list":["post-19598","post","type-post","status-publish","format-standard","hentry","category-subscriber-content"],"_links":{"self":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/19598","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/comments?post=19598"}],"version-history":[{"count":1,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/19598\/revisions"}],"predecessor-version":[{"id":19599,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/19598\/revisions\/19599"}],"wp:attachment":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media?parent=19598"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/categories?post=19598"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/tags?post=19598"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}